My SharePad Articles

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

23 April 2021
By Maynard Paton

I like companies that boast significant net cash. My reasons include:

• Limited risk of funding difficulties should trouble strike;
• Management might be sensible by holding ‘rainy day’ money;
• The cash position may have resulted from superb profit generation, and;
• The share price could be less volatile (especially if the cash position represents a large part of the market cap).

I therefore applied the following filter criteria within SharePad to identify some reasonable cash-flush businesses:

• Trailing twelve-month net borrowings of no more than zero (i.e. a net cash position);
• A market cap of at least £50 million;
• Net cash of at least 10% of the market cap, and;
• A trailing twelve-month operating margin of at least 1% (to include only profitable companies).

I found 38 matches, and Venture Life attracted my attention because the company:

• Carried a significant 28% of its market cap as net cash;
• Operated within the generally favourable healthcare sector, and;
• Published impressive results last month.

Read my full Venture Life article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

24 March 2021
By Maynard Paton

Let me start by confessing this article covers pension deficits.

What follows may not be that thrilling and does require you to concentrate. But please stick with me, especially if you have ever fallen victim to a ‘value trap’.

A burdensome pension scheme is a common reason why companies trade on permanently low ratings. The market essentially believes too much of their future profits will have to plug a retirement ‘black hole’ instead of being paid out as dividends.

A good example is Norcros, a £214 million manufacturer of bathroom showers, taps and tiles.

This share has stubbornly traded on a single-digit P/E for years…

… and studying the group’s pension situation goes some way to explain why.

Read my full Norcros article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

10 March 2021
By Maynard Paton

One of my favourite SharePad screens identifies good-quality companies that have grown without acquisition. The screen uses the following filter criteria:

• Positive five-year turnover and operating profit growth;
• A minimum 15% for both return on equity and operating margin;
• Net borrowing of no more than zero (i.e. a net cash position), and;
• A five-year acquisition spend of zero.

I ran the screen the other day and found 28 matches. I studied Best of the Best — or BOTB as it now calls itself — because I was already aware of:

• Some very remarkable financials;
• An extraordinary share-price performance, and;
• Management deciding not to sell the business despite “extensive talks with a range of parties”.

Read my full Best of the Best article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

24 February 2021
By Maynard Paton

Let’s start with a wealth warning:

• This article covers bitcoin miner Argo Blockchain;
• I am not a bitcoin expert;
• The bitcoin price is highly unpredictable;
• Argo’s share price is highly unpredictable, and;
• Argo issues frequent updates.

Still, Argo is a company worth studying… not least because the shares have soared 25-fold in just two months:

Let’s find out what is happening.

Read my full Argo Blockchain article for SharePad.

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

11 February 2021
By Maynard Paton

For some time now IG Group has been flashing on my SharePad filters.

According to my screens, the spread-betting firm offers:

• High margins;
• Decent returns on equity;
• Cash-rich accounts;
• Attractive five-year growth;
• A lack of past acquisitions, and;
• A modest P/E.

Those characteristics are an unusual mix in a market presently bereft of obvious quality bargains.

Let’s take a closer look.

Read my full IG Group article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

29 January 2021
By Maynard Paton

I have started a series of occasional articles for SharePad in which I shine an investigative spotlight on particular small-caps.

My aim is to demonstrate how to analyse companies in SharePad and beyond to help you become a more informed investor.

I start with LoopUp, a £44 million developer of software for remote meetings and conference calls.

The other month the company issued a sales warning that caused a 50% share-price crash.

LoopUp should have been a pandemic winner last year selling its remote-meeting systems… so why has the company disappointed?

Read my full LoopUp article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

21 January 2021
By Maynard Paton

Happy 2021!

I trust SharePad will help bring you good fortune in what could be another twelve months of financial thrills and spills.

As usual I plan to trawl the market for interesting shares that I hope assists your company analysis and stock-picking.

I start the year with Avon Rubber, a FTSE 250 member that has rewarded shareholders handsomely since 2009 but recently experienced a trading wobble.

Read my full Avon Rubber article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

20 November 2020
By Maynard Paton

I am always looking for ‘multi-baggers’ — investments that can double, triple, quadruple or more.

And here’s some very good news: I have stumbled on a company that can find them for me.

Not just the occasional five-bagger or ten-bagger mind, but 20-baggers.

It’s incredible stuff, especially as the track record of success extends for many years and the gains are typically realised within twelve months.

The company behind these multi-baggers is Manolete Partners, which I discovered by employing a very straightforward SharePad screen.

Read my full Manolete Partners article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

05 November 2020
By Maynard Paton

Today I have returned to one of my favourite SharePad screens.

This screen applies two ratios favoured by ‘quality’ investors — operating margin and return on equity (ROE).

The main filter criteria are:

• An operating margin (latest and 10-year average) of 20% or more, and;
• An ROE (latest and 10-year average) of 20% or more.

Any business with a margin and ROE consistently above 20% is probably quite special.

I ran the screen and decided to study Jarvis Securities, a small stock-broker best known for x-o.co.uk.

Read my full Jarvis Securities article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

30 September 2020
By Maynard Paton

I am not a great fan of the fund-management industry.

I cannot think of another sector where the employees collect enormous salaries while the customers pay hefty fees and sometimes get nothing in return.

Quite often us amateur investors are better off with simple index trackers rather than falling for the industry’s persuasive advisers and glossy brochures.

Yet here I am about to study Polar Capital — a fund manager that might actually exhibit ‘pandemic proof’ qualities given its investment bias towards technology and healthcare.

Read my full Polar Capital article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

10 September 2020
By Maynard Paton

First, a wealth warning.

The last price-to-book ‘bargain’ I looked at for SharePad was Hammerson.

Back then investors were in theory able to purchase £1 of assets for just 30p. The share price has since lost 75%.

A few tweaks to the same stock screen now leads me to Fuller, Smith & Turner. 

This pub group has suffered during the pandemic, but sleuthing via SharePad reveals substantial freehold assets that the balance sheet may significantly undervalue. 

This property backing may limit further downside as the group re-opens its pubs and aims to recover.

Read my full Fuller, Smith & Turner article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

29 July 2020
By Maynard Paton

They say mums always know best.

Mine has bought Fever-Tree tonic waters for some years now and I recently asked whether she remained a customer. This was her response.

“While we don’t buy many commercial drinks for home consumption these days I would still definitely buy Fever-Tree, generally the original tonic water. I went into an actual shop (M&S) last week for the first time and spotted the selection of Fever-Tree drinks. I was tempted at the time but as the weather was poor decided against it.

If we were having visitors it would definitely be purchased. When going out with certain knowledgeable friends for lunch etc, Fever-Tree is always the drink of choice. If the cafe/restaurant doesn’t sell Fever-Tree it is ‘downgraded’ on our rating and generally abandoned. Availability of Fever-Tree is, to us, a sign of caring about quality.”

I had no idea mum regarded the drinks so highly. If she is representative of every Fever-Tree customer, then maybe the company deserves our attention.

Read my full Fever-Tree Drinks article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

19 July 2020
By Maynard Paton

Let me start by thanking you for showing interest in an article with Headlam in the title.

Rest assured, not everyone will want to read about this rather dull business that has suffered badly during the pandemic.

But for us contrarians, now may be the time to consider such stocks — unloved names that the market rebound has left far behind.

Headlam seems to possess the industry position, balance-sheet strength and management experience to survive this downturn and recover thereafter. A full share-price recovery could even offer a potential 100% gain.

Read my full Headlam article for SharePad.

Maynard Paton

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

11 June 2020
By Maynard Paton

Has the market become too obsessed with ‘pandemic-proof’ shares?

I ask because my SharePad screening has brought Frontier Developments to my attention.

The shares of this computer-game developer have leapt 66% so far this year as industry sales rally during the lockdown.

However, Frontier’s accounting looks rather questionable and the near-£800 million market cap seems completely mad. Yet nobody seems to mind given the company’s apparent resilience to Covid-19.

Read my full Frontier Developments article for SharePad.

Maynard Paton

PS: I have also compared Frontier’s accounting to that of Team17 and Codemasters.

PPS: I have provided further Frontier observations on the Quidisq forum.

***SharePad New Subscriber Special Offer***
Readers of my blog can claim one month of free data. Click here for details.

14 May 2020
By Maynard Paton

One way to invest during the pandemic is to consider shares that have climbed higher as the market has dropped.

Such companies may well be ‘safe havens’ — businesses that are coping well with the lockdown, or perhaps even benefitting from the crisis.

I applied the following simple criteria within SharePad to identify potential ‘pandemic-proof’ names:

• A share-price change this year of 0% or more;
• A market cap of £250 million or more, and;
• A profit of £1m or more.

On my shortlist was Hikma Pharmaceuticals, which has rallied 17% so far this year. Other attractions included:

• An appealing 22% margin and 19% return on equity;
• Profit being twice the level of debt;
• A forecast 18x P/E not appearing too extreme, and;
• The directors owning a useful shareholding.

Read my full Hikma Pharmaceuticals article for SharePad.

Maynard Paton